| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,2 M € | +6.3% | 3,9 M € | +23.4% | 3,2 M € | +7.8% | 2,9 M € | -21.2% | 3,7 M € | +5.2% | 3,5 M € | +40.3% | 2,5 M € | -55.2% | 5,6 M € | -66.2% | 16,7 M € | +84.4% | 9,1 M € | +94.4% | 4,7 M € | +57.4% | 3,0 M € | -12.9% | 3,4 M € | -1.2% | 3,4 M € | +81.7% | 1,9 M € | -2.0% | 1,9 M € | +57.4% | 1,2 M € | -12.4% | 1,4 M € | +67.3% | 837,2 k € | -50.1% | 1,7 M € | |
| EBITDA | -7,6 k € | +99.8% | -3,2 M € | +41.7% | -5,5 M € | +34.3% | -8,4 M € | -53.3% | -5,5 M € | -3602.0% | 157,2 k € | +104.7% | -3,4 M € | -144.2% | -1,4 M € | -112.2% | 11,4 M € | +368.3% | 2,4 M € | +231.3% | -1,8 M € | -17.7% | -1,6 M € | +21.5% | -2,0 M € | +3.5% | -2,1 M € | +60.2% | -5,2 M € | +37.8% | -8,4 M € | +30.3% | -12,0 M € | -44.0% | -8,3 M € | +1.5% | -8,5 M € | +1.0% | -8,5 M € | |
| Operating profit | -4,3 M € | +26.4% | -5,9 M € | +21.7% | -7,5 M € | +19.1% | -9,3 M € | -67.7% | -5,5 M € | -4061.3% | 139,3 k € | +104.1% | -3,4 M € | -140.1% | -1,4 M € | -112.9% | 10,9 M € | +355.1% | 2,4 M € | +225.6% | -1,9 M € | -10.5% | -1,7 M € | +28.8% | -2,4 M € | -1.1% | -2,4 M € | +57.3% | -5,6 M € | +37.6% | -9,0 M € | +34.0% | -13,7 M € | -36.7% | -10,0 M € | +0.5% | -10,1 M € | -2.5% | -9,8 M € | |
| Profit/loss | -4,1 M € | -158.9% | 7,0 M € | +124.8% | -28,4 M € | +40.7% | -47,8 M € | -549.6% | -7,4 M € | -383.7% | -1,5 M € | +98.6% | -111,4 M € | -22139.4% | 505,7 k € | -95.8% | 12,0 M € | +220.3% | 3,7 M € | +490.7% | -958,3 k € | +12.1% | -1,1 M € | +61.9% | -2,9 M € | -7.7% | -2,7 M € | +60.8% | -6,8 M € | +23.7% | -8,9 M € | +45.0% | -16,1 M € | -81.2% | -8,9 M € | +2.1% | -9,1 M € | +2.5% | -9,3 M € | |
| Equity | 134,0 M € | -0.2% | 134,3 M € | +53.8% | 87,3 M € | +16.5% | 74,9 M € | -36.4% | 117,8 M € | +92.7% | 61,1 M € | +22.5% | 49,9 M € | -67.2% | 152,4 M € | +31.5% | 115,9 M € | +11.8% | 103,7 M € | +30.8% | 79,3 M € | +66.5% | 47,6 M € | +30.9% | 36,4 M € | +71.3% | 21,2 M € | +52.8% | 13,9 M € | +11.0% | 12,5 M € | -41.5% | 21,4 M € | -42.8% | 37,4 M € | -0.5% | 37,6 M € | +7.4% | 35,0 M € | |
| Total assets | 159,3 M € | -8.8% | 174,7 M € | +29.9% | 134,4 M € | +7.8% | 124,7 M € | -8.4% | 136,1 M € | +90.6% | 71,4 M € | +10.5% | 64,6 M € | -59.9% | 161,0 M € | +35.4% | 118,9 M € | -0.8% | 119,8 M € | +28.7% | 93,1 M € | +73.1% | 53,8 M € | +42.5% | 37,8 M € | +64.2% | 23,0 M € | +22.3% | 18,8 M € | +4.2% | 18,0 M € | -32.1% | 26,6 M € | -36.9% | 42,1 M € | -2.0% | 43,0 M € | +11.5% | 38,5 M € | |
| Cash | 20,3 M € | -52.5% | 42,8 M € | +126.8% | 18,9 M € | +59.3% | 11,8 M € | -76.3% | 49,9 M € | +343.8% | 11,2 M € | -30.9% | 16,3 M € | -26.5% | 22,1 M € | +77.6% | 12,5 M € | -55.7% | 28,1 M € | -1.1% | 28,5 M € | +85.8% | 15,3 M € | -12.8% | 17,6 M € | +55.4% | 11,3 M € | +965.7% | 1,1 M € | +27.1% | 834,2 k € | -24.1% | 1,1 M € | -6.2% | 1,2 M € | +380.5% | 243,9 k € | -98.9% | 22,6 M € | |
| Debts | 19,1 M € | -14.2% | 22,3 M € | -36.3% | 35,0 M € | -2.9% | 36,0 M € | +219.3% | 11,3 M € | +10.1% | 10,2 M € | -1.4% | 10,4 M € | +453.9% | 1,9 M € | +1.4% | 1,9 M € | -40.1% | 3,1 M € | -10.4% | 3,4 M € | +96.3% | 1,8 M € | +28.5% | 1,4 M € | -21.2% | 1,7 M € | -61.4% | 4,5 M € | -0.2% | 4,5 M € | +3.9% | 4,3 M € | +75.7% | 2,5 M € | -28.6% | 3,5 M € | +14.8% | 3,0 M € | |
| Staff | 0 | 1 | 1,5 | 2,6 | 2,6 | 2,8 | 3,7 | 5,3 | 5,5 | 6,3 | 6,6 | 8,6 | 13,4 | 21,1 | 20,3 | 24,9 | 23,9 | 23,9 | 31,3 | 26,4 | ||||||||||||||||||||
Public limited company · Herstal · incorporated on 15/01/2003 · 0,0 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-52.5%).
Solid counterparty for a standard engagement.
MDxHealth is a Public limited company incorporated in 2003. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Herstal.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette